Metformin and oncogenic pathways: Crosstalk between energy sensing and tumor progression
Metformin, a widely prescribed oral biguanide for type 2 diabetes mellitus, has gained significant attention as a potential anti-cancer agent. Beyond its established role in improving insulin sensitivity and lowering blood glucose, preclinical and epidemiological studies suggest that metformin exert...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier
2026-04-01
|
| Schriftenreihe: | Molecular and Cellular Probes |
| Schlagworte: | |
| Online-Zugang: | http://www.sciencedirect.com/science/article/pii/S0890850826000083 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|